Tele: 561.316.3330
Breaking Medical Device News

Friday, October 15, 2021

HomeBIOTECHNOLOGYEVOTEC EXPANDS IPSC DRUG DISCOVERY LEADERSHIP THROUGH STRATEGIC COLLABORATION WITH CENSO BIOTECHNOLOGIES

EVOTEC EXPANDS IPSC DRUG DISCOVERY LEADERSHIP THROUGH STRATEGIC COLLABORATION WITH CENSO BIOTECHNOLOGIES

Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today announced a collaboration with Censo Biotechnologies Ltd. (“Censo”) to source and provide patient-derived induced pluripotent stem cells (“iPSC”) to support Evotec’s broad iPSC platform.

Censo will provide its sourcing and reprogramming technologies and expertise to create a high-quality, bespoke repository of hundreds of patient-derived iPS cell lines, covering multiple diseases with an initial focus on CNS diseases. The contract will run for an initial period of two years.

Dr Cord Dohrmann, Chief Scientific Officer of Evotec, commented: “We are very pleased to have teamed up with Censo, a proven leader in the field of iPSCs – covering in particular the sourcing of donor cells, the generation of iPS cell lines as well as extensive characterisation and quality control. Their platform will support and complement Evotec’s use of patient-derived disease models for drug screening and the discovery of more disease-relevant drug candidates.”

Aidan Courtney, CEO of Censo Biotechnologies, noted: “Both Censo and Evotec believe in the enabling power of patient-derived iPSCs as a drug discovery tool. This collaboration is a validation of Censo’s extensive network, technology platform and expertise in this space. We look forward to working closely with our colleagues at Evotec and supporting their ambitious plans for iPSC-based drug discovery.”

No financial details were disclosed.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

By using this website you agree to accept Medical Device News Magazine Privacy Policy